Pinkelpause

www.doc-pies.de

Köhn FM, Schultheiss D, Krämer-Schultheiss K. Teil 1 - Hauterkrankungen am äußeren männlichen Genitale. Urologe A 201; 55:829-842

Köhn FM. Hauterkrankungen im Genitalbereich des Mannes. Der Hautarzt 2016; 67:793- 805

Köhn FM. Erkrankungen des männlichen Genitales. In: Plewig G, Landthaler M, Burgdorf WHC, Ruzicka T (Hrsg.) Braun-Falcos Dermatologie, Venerologie und Allergologie. Springer-Verlag, Heidelberg 2012, S. 1376-1389

Köhn FM, Schultheiss D, Krämer-Schultheiss K. Hauterkrankungen am äußeren männlichen Genitale (Teil 2) Maligne und infektiöse Hauterkrankungen. Urologe A 2016; 55:981-996

Edwards SK, Bunker CB, Ziller F, van der Meijden WI. 2013 European guideline for the management of balanoposthitis. Int J STD AIDS 2014; 25: 615-626.

Mallon E, Hawkins D, Dinneen M, Francics N, Fearfield L, Newson R, Bunker C. Circumcision and genital dermatoses. Arch Dermatol 2000; 136:350-354

Haag A, Möhrenschlager M, Ring J, Köhn FM. Diagnostik sexuell übertragbarer Krankheiten: Pilzinfektionen. MMW Fortschr Med 2004; 150:28-30

Julián-Gónzalez RE, Orozco-Covarrubias L, Durán-McKinster C, Palacios-Lopez C, Ruiz-Maldonado R, Sáez-de-Ocariz M. Less common clinical manifestations of atopic dermatitis: prevalence by age. Pediatr Dermatol 2012; 29:580-583

You HS, Kim GW, Kim WJ, Mun JH, Song M, Kim HS, Ko HC, Kim BS, Kim MB. Dermatoses of the Glans Penis in Korea: A 10-Year Single Center Experience. Ann Dermatol 2016; 28:40-44

www.doc-pies.de

Ali H, Guy RJ, Wand H et al (2013) Decline in inpatient treatments of genital warts among young Australians following the national HPV vaccination program. BMC Infect Dis 13:140-146

Arbyn M, de Sanjose S, Saraiya M et al (2012) EUROGIN 2011 roadmap on prevention and treatment of HPV-related disease. Int J Cancer 131:1969-1982

Giuliano AR, Palefsky JM, Goldstone S et al (2011) Efficacy of quadrivalent HPV vaccine against HPV Infection and disease in males. N Engl J Med 364:401-411

Gross G, Becker N, Brockmeyer NH et al (2013) S3-Leitlinie zur Impfprävention HPV-assoziierter Neoplasien.(AWMF-Register-Nr.: 082/002)

Gross GE, Werner RN, Becker JC et al (2018) S2k Leitlinie HPV-assoziierte Läsionen der äußeren Genitalregion und des Anus-Genitalwarzen und Krebsvorstufen der Vulva, des Penis und der peri- und intraanalen Haut. (AWMF-Registernummer: 082-008)

Klug SJ, Meerpohl J, Röbl-Mathieu M et al (2018) HPV-Impfung. Auch Jungen können profitieren. Dtsch Arztebl 115:A1382-A1386

Kraut AA, Schink T, Schulze-Rath R et al (2010) Incidence of anogenital warts in Germany: a population-based cohort study. BMC Infect Dis 10:360

Preaud E, Largeron N (2013) Economic burden of non-cervical cancers attributable to human papillomavirus: a European scoping review. J Med Econ 16:763-776

Schneede P (2017) Ein Jahrzehnt der HPV-Impfung in Deutschland. Urologe 56:728-733

Schneede, P. Krankheitslast humaner Papillomaviren der Männer. Urologe 57, 1452-1456 (2018).

www.doc-pies.de

Burstein GR et al. (2003) Sexually transmitted diseases treatment guidelines. Curr Opin Pediatr 15: 391-397.

Donovan B, Grulich AE. 2011. The quadrivalent HPV vaccine is effective prophylaxis against HPV-related external genital lesions in young men. Evid Based Med. 16(5):157-8

Delere Y, Remschmidt C, Leuschner J, et al. Human Papillomavirus prevalence and probable first effects of vaccination in 20 to 25 year-old women in Germany: a population-based cross-sectional study via home-based self-sampling. BMC Infect Dis 2014;14:87

de Martel C, Ferlay J, Franceschi S, et al. Global burden of cancers attributable to infections in 2008: a review and synthetic analysis. Lancet Oncol 2012;13(6):607-15

Doorbar J, Quint W, Banks L, et al. The biology and life-cycle of human papillomaviruses. Vaccine 2012;30 Suppl 5:F55-70

Kraut AA, Schink T, Schulze-Rath R, et al. Incidence of anogenital warts in Germany: a population-based cohort study. BMC Infect Dis 2010;10:360

McCredie MR, Sharples KJ, Paul C, et al. Natural history of cervical neoplasia and risk of invasive cancer in women with cervical intraepithelial neoplasia 3: a retrospective cohort study. Lancet Oncol 2008;9(5):425-34

Bauer GR, Khobzi N, Coleman TA. Herpes simplex virus type 2 seropositivity and relationship status among U.S. adults age 20 to 49: a population-based analysis. BMC Infect Dis. 2010 Dec 22;10:359.

Fleming DT, McQuillan GM, Johnson RE, Mahmias AJ, Aral SO, Lee FK, St Louis ME. Herpes simplex virus type 2 in the United States, 1976 to 1994. New Engl J Med. 1997;337:1105-1111.

Hellenbrand W, Müller B, Thierfelder W, Färber I, Hamouda O, Breuer T. 2001. Die Herpes simplex-Virus 1 (HSV1) und 2 (HSV2) Seroprävalenz in der deutschen Bevölkerung: Ein Vergleich zwischen den alten und neuen Bundesländern und Veränderungen über die Zeit. Jahrestagung der Deutschen Arbeitsgemeinschaft für Epidemiologie. Garmisch-Partenkirchen: GSF-Forschungszentrum für Umwelt und Gesundheit.

Korr G, Thamm M, Czogiel I, Poethko-Mueller C, Bremer V, Jansen K. Decreasing seroprevalence of herpes simplex virus type 1 and type 2 in Germany leaves many people susceptible to genital infection: time to raise awareness and enhance control. BMC Infectious DiseasesBMC series open, inclusive and trusted2017 17:471.

Malkin CE. Epidemiology of genital herpes simplex virus infection in developed countries. Herpes. 2004 Apr;11 Suppl 1:2A-23A.

www.doc-pies.de

Decker CF. Sexually transmitted diseases: An overview. Dis Mon. 2016;62(8):258-259.

Sheaves C. Sexually transmitted infection updates: recommendations from the CDC. Nurse Pract. 2012;37(9):43-46.

Sulak PJ. Sexually transmitted diseases. Semin Reprod Med. 2003;21(4):399-413.

Da Ros CT, Schmitt Cda S. Global epidemiology of sexually transmitted diseases. Asian J Androl. 2008;10(1):110-114.

Moi H, Blee K, Horner PJ. Management of non-gonococcal urethritis. BMC Infect Dis. 2015;15:294.

Global Prevalence and Incidence of Selected Sexually Transmitted Diseases. Geneva: World Health Organization, 2001

Gille G, Klapp C et al.: Chlamydien – eine heimliche Epidemie unter Jugendlichen. Deutsches Ärzteblatt 2005; 102 (28–29):A2021–A2025

Centers for Disease Control and Prevention: Sexually Transmitted Diseases Treatment Guidelines, 2006. MMWR 2006; 55:38–42

Screening auf genitale Chlamydia trachomatis-Infektionen bei Frauen. Abschlussbericht des Unterausschusses „Familienplanung“ des G-BA, 30. Januar 2008

Bignell C. 2009 European (IUSTI/WHO) guideline on the diagnosis and treatment of gonorrhoea in adults. Int J STD AIDS. 2009 Jul;20(7):453-7.

Robert Koch-Institut (RKI). 2010. Syphilis in Deutschland im Jahr 2009. Epidemiologisches Bulletin 49: 487-489.

Phipps W, Kent CK, Kohn R, Klausner JD: Risk factors for repeat syphilis in men who have sex with men, San Francisco. Sex Transm Dis 2009; 36 (6): 331 - 335

www.doc-pies.de

Owen DH, Katz DF: A Review of the Physical and Chemical Properties of Human Semen and the Formulation of a Semen Simulant. In: Journal of Andrology. Band 26, Nr. 4, Juli-August 2005, 5.459-469

Cooper TG: WHO laboratory manual for the examination and processing of human semen, WHO press, Geneva, Switzerland, 2010

Veale D, Miles S, Bradley S, Muir G, Hodsoll J: Am I normal? A systematic review and construction of nomograms for flaccid and erect penis length and circumference in up to 15521 men, BJU International: 08 December 2014 https://doi.org/ 10.111 1/bju.13010

Shelton JD: Masturbation: Breaking the Silence. International Perspectives on Sexual and Reproductive Health; New York Bd. 36, Ausg. 3, (Sep 2010): 157-8.

Waldinger MD et al: A multinational population survey of intravaginal ejaculation latency time. The Journal of Sexual Medicine 2005 Jul; 2(4): 492-7.

Kreutzer N et al: Ejaculatio praecox – Eine Studie zur durchschnittlichen koitalen Immissionsdauer und aktueller Stand der Literatur – Premature Ejaculation – A Study of Average Ejaculation Time and Overview of the Literature, Aktuelle Urologie 2001; 32(7): 435-438

Cai L et al: Premature ejaculation results from partners’ mismatch: development and validation of index of intra-vaginal ejaculation latency time. International Journal of Impotence Research, 2016; 28: 101–5

Porst H et al: The Premature Ejaculation Prevalence and Attitudes (PEPA) survey: prevalence, comorbidities, and professional help-seeking. European Urology 2007 Mar; 51(3): 816-23

Waldinger MD, Quinn P, Dilleen M, Mundayat R, Schweitzer DH, Boolell M: A multinational population survey of intravaginal ejaculation latency time. J Sex Med. 2005 Jul; 2(4): 492-7.

Grammer K, Fink B et al: Human pheromones and sexual attraction, Eur J Obstet Gynecol Reprod Biol, 2005 Feb 1; 118(2): 135-42

Bremer V et al: Sexuell übertragbare Infektionen in Deutschland. Die aktuelle epidemiologische Lage. Bundesgesundheitsbl 2017 · 60:948-957

www.doc-pies.de

Nguyen HMT, Gabrielson AT, Hellstrom WJG. Erectile Dysfunction in Young Men-A Review of the Prevalence and Risk Factors. Sex Med Rev. 2017 Oct;5(4):508-520.

Cohen SD: The Challenge of Erectile Dysfunction Management in the Young Man. Curr Urol Rep. 2015 Dec;16(12):84.

Ludwig W, Phillips M. Organic causes of erectile dysfunction in men under 40. Urol Int. 2014;92(1):1-6.

Maiorino MI et al. Erectile dysfunction in young men with type 1 diabetes. Int J Impot Res. 2017 Jan;29(1):17-22.

Rajkumar RP. The impact of disrupted childhood attachment on the presentation of psychogenic erectile dysfunction: An exploratory study. J Sex Med 2015;12:798–803.

Wiggins A et al. A treatment algorithm for healthy young men with erectile dysfunction, BJU Int 2019; 123: 173-179

Pressemitteilung, Deutsche Gesellschaft für Mann und Gesundheit, 7. April 2020

Twenge JM, Sherman RA, Wells BE: Declines in Sexual Frequency among American Adults, 1989-2014. Arch Sex Behav. 2017 Nov; 46(8): 2389-2401

Bertelsmann-Stiftung, „Video-Sprechstunden“, Spotlight Gesundheit, 1. Auflage 2015 ISBN 2364-5970

www.aerzteblatt.de vom 16. März 2020:

www.welt.de vom 28.03.2020: „Jetzt schlägt die Stunde der Telemedizin“

Park, S., Won, D.D., Lee, B.J. et al. A mountable toilet system for personalized health monitoring via the analysis of excreta. Nat Biomed Eng 4, 624–635 (2020).

www.doc-pies.de

https://podcasts.apple.com/nl/podcast/der-potcast-cannabis-hype-oder-hope/id1445172161?i=1000433819802

Allen MS, Walter EE. Health-Related Lifestyle Factors and Sexual Dysfunction: A Meta-Analysis of Population-Based Research. J Sex Med 2018;15:458-475.

Sun AJ, Eisenberg ML: Association Between Marijuana Use and Sexual Frequency in the United States: A Population-Based Study. J Sex Med. 2017 Nov;14(11):1342-1347.

Payne KS, Mazur DJ, Hotaling JM, Pastuszak AW: Cannabis and Male Fertility: A Systematic Review. J Urol. 2019 Oct;202(4):674-681

Aversa A1, Rossi F, Francomano D, Bruzziches R, Bertone C, Santiemma V, Spera G: Early endothelial dysfunction as a marker of vasculogenic erectile dysfunction in young habitual cannabis users. Int J Impot Res. 2008 Nov-Dec;20(6):566-73.

Muniyappa R et al: Metabolic effects of chronic cannabis smoking. Diabetes Care. 2013 Aug;36(8):2415-22.

Smith AMA, Ferris JA, Simpson JM, Shelley J, Pitts M, and Richters J. Cannabis use and sexual health. J Sex Med 2010;7:787-793.

Thackeray, Francis. (2015). Shakespeare, plants, and chemical analysis of early 17th century clay 'tobacco' pipes from Europe. South African Journal of Science, 111(7-8), 1-2.

Gurney J, Shaw C, Stanley J, Signal V, Sarfati D. Cannabis exposure and risk of testicular cancer: a systematic review and meta-analysis. BMC Cancer. 2015;15:897.

Callaghan RC, Allebeck P, Akre O, McGlynn KA, Sidorchuk A. Cannabis Use and Incidence of Testicular Cancer: A 42-Year Follow-up of Swedish Men between 1970 and 2011. Cancer Epidemiol Biomarkers Prev. 2017;26(11):1644‐1652.

www.doc-pies.de

https://podcast8ac3b6.podigee.io/65-65-erektionsstorung-antenne-des-herzens

Yuan, J; Hoang, AN; Romero, CA; Lin, H; Dai, Y; Wang, R (2010): Vacuum therapy in erectile dysfunction - science and clinical evidence. International Journal of Impotence Research, Vol. 22, Issue 4, Pages 211-219.

Porst et al, 1998, results of a long term European study, Int J Impotence Res 10, 225 - 231

Stief C.G. et al., Dtsch. Ärzteblatt 97, C370, 2000

Limoge, J.P. et al: Minimally invasive therapies in the treatment of erectile dysfunction in anticoagulated cases, J Uro 155, 1277-1279, 1996

https://www.netdoktor.de/therapien/penisprothese/

www.doc-pies.de

https://podcast8ac3b6.podigee.io/65-65-erektionsstorung-antenne-des-herzens

Wiad Lek. 2016;69:576-581.

J Sex Med. 2019 Feb;16(2):223-234.

www.doc-pies.de

https://podcast8ac3b6.podigee.io/65-65-erektionsstorung-antenne-des-herzens

Goldstein I et al: Oral sildenafil in the treatment of erectile dysfunction. Sildenafil Study Group. In: N Engl J Med, 1998; 338 (20), S. 1397-1404

Scaglione F, Donde S, Hassan TA, Jannini EA: Phosphodiesterase Type 5 Inhibitors for the Treatment of Erectile Dysfunction: Pharmacology and Clinical Impact of the Sildenafil Citrate Orodispersible Tablet Formulation. Clin Ther. 2017 Feb; 39(2): 370-377.

Albersen M et al: The future is today: emerging drugs for the treatment of erectile dysfunction. Expert Opin Emerg Drugs. 2010 Sep; 15(3): 467-480.